ArticlePancreas2026
The Association Between Serum Uric Acid to Creatinine Ratio and the Severity of Acute Pancreatitis.
Article in Pancreas, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo examine the relationship between the serum uric acid to creatinine ratio (SUA/SCr) and the severity of acute pancreatitis.
methodsA total of 1612 patients diagnosed with acute pancreatitis at the Affiliated Hospital of Qingdao University were enrolled in this study. Patients were categorized into 2 groups: mild acute pancreatitis (MAP) and severe acute pancreatitis (SAP). Demographic data, including sex and age, along with biochemical indicators such as white blood cell count, arterial blood pH, glucose, triglycerides, and serum calcium, were collected and analyzed.
resultsAmong the 1612 patients, those with lower SUA/SCr levels were at an increased risk of developing severe acute pancreatitis ( P =0.026, OR=0.81, 95% CI: 0.72-0.98). Restricted cubic spline (RCS) analysis revealed a nonlinear, U-shaped relationship between SUA/SCr and the risk of severe acute pancreatitis. A clinical prediction model was developed, achieving an area under the curve (AUC) of 0.81.
conclusionLower SUA/SCr levels are associated with an elevated risk of severe acute pancreatitis. These findings suggest that SUA/SCr may serve as a valuable biomarker for predicting the severity of acute pancreatitis in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.